Literature DB >> 25736684

Bufalin is a steroid receptor coactivator inhibitor-response.

David M Lonard1, Jianming Xu1, Bert W O'Malley2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25736684      PMCID： PMC5523467          DOI： 10.1158/0008-5472.CAN-14-2648

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

1.  Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.

Authors:  Ying Wang; David M Lonard; Yang Yu; Dar-Chone Chow; Timothy G Palzkill; Jin Wang; Ruogu Qi; Alexander J Matzuk; Xianzhou Song; Franck Madoux; Peter Hodder; Peter Chase; Patrick R Griffin; Suoling Zhou; Lan Liao; Jianming Xu; Bert W O'Malley
Journal:  Cancer Res       Date:  2014-01-03       Impact factor: 12.701

Review 2.  Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients.

Authors:  Pei-Hao Yin; Xuan Liu; Yan-Yan Qiu; Jian-feng Cai; Jian-min Qin; Hui-Rong Zhu; Qi Li
Journal:  Asian Pac J Cancer Prev       Date:  2012

3.  Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.

Authors:  Noriyuki Takai; Tami Ueda; Masakazu Nishida; Kaei Nasu; Hisashi Narahara
Journal:  Int J Mol Med       Date:  2008-05       Impact factor: 4.101

4.  Human breast tumor cells are more resistant to cardiac glycoside toxicity than non-tumorigenic breast cells.

Authors:  Rebecca J Clifford; Jack H Kaplan
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240
  4 in total
  2 in total

Review 1.  New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin.

Authors:  Chien-Shan Cheng; Jiaqiang Wang; Jie Chen; Kuei Ting Kuo; Jian Tang; Huifeng Gao; Lianyu Chen; Zhen Chen; Zhiqiang Meng
Journal:  Cancer Cell Int       Date:  2019-04-11       Impact factor: 5.722

2.  Surfactant Assisted Rapid-Release Liposomal Strategies Enhance the Antitumor Efficiency of Bufalin Derivative and Reduce Cardiotoxicity.

Authors:  Lina Gao; Lei Zhang; Fengjun He; Jing Chen; Meng Zhao; Simin Li; Hao Wu; Yumeng Liu; Yinan Zhang; Qineng Ping; Lihong Hu; Hongzhi Qiao
Journal:  Int J Nanomedicine       Date:  2021-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.